Court Dismisses False-Claims Suit Against Boston Scientific
The court said the plaintiff in the case, a former Boston Scientific medical advisor, didn’t prove that the company had concealed safety data from the US FDA.
You may also be interested in...
The recall is related to potential false positives that may occur if a genuine positive test sample overflows into an adjacent sample that would have otherwise tested negative.
The agency asked consultants Booz Allen Hamilton to evaluate its handling of diagnostic EUAs as a way to prepare for potential future pandemics.
Benjamin Wallfisch, a senior attorney at the Office of the Inspector General in the US Department of Health and Human Services, recently discussed how companies can avoid apparent violations of anti-kickback law while hosting educational programs.